News
ZLAB
26.34
+1.58%
0.41
Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Barchart · 1d ago
Weekly Report: what happened at ZLAB last week (0921-0925)?
Weekly Report · 2d ago
Weekly Report: what happened at ZLAB last week (0914-0918)?
Weekly Report · 09/21 09:41
Zai Lab Ltd (1ZLB) Receives a Buy from UBS
TipRanks · 09/18 00:25
Weekly Report: what happened at ZLAB last week (0907-0911)?
Weekly Report · 09/14 09:43
Limoneira Posts Downbeat Q3 Results, Joins Cooper Companies, Navan And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
Benzinga · 09/10 12:02
Weekly Report: what happened at ZLAB last week (0831-0904)?
Weekly Report · 09/07 09:40
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Benzinga · 09/02 14:26
J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
TipRanks · 09/02 12:18
Weekly Report: what happened at ZLAB last week (0824-0828)?
Weekly Report · 08/31 09:44
Zai Lab price target raised to $36 from $27 at JPMorgan
TipRanks · 08/27 13:15
Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TipRanks · 08/26 05:16
Weekly Report: what happened at ZLAB last week (0817-0821)?
Weekly Report · 08/24 09:44
Zai Lab: Revenue Growth And Zoci's Upside Optionality
Seeking Alpha · 08/19 04:17
Zai Lab Earnings Call Highlights Pipeline-Driven Upside
TipRanks · 08/18 00:07
Weekly Report: what happened at ZLAB last week (0810-0814)?
Weekly Report · 08/17 09:45
Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
Barchart · 08/17 05:00
Morgan Stanley Sticks to Its Buy Rating for Zai Lab Ltd (1ZLB)
TipRanks · 08/12 00:25
Citic Securities Sticks to Its Buy Rating for Zai Lab Ltd (1ZLB)
TipRanks · 08/12 00:25
Weekly Report: what happened at ZLAB last week (0803-0807)?
Weekly Report · 08/10 09:42
More
Webull provides a variety of real-time ZLAB stock news. You can receive the latest news about Zai Lab Limited through multiple platforms. This information may help you make smarter investment decisions.
About ZLAB
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.